Close Menu

NEW YORK — Quotient Limited on Friday said that it has received CE marking for its serological disease screening (SDS) microarray.

The test runs on the company's CE marked Mosaiq system for blood grouping and transfusion-transmitted infection screening. It is designed to detect syphilis and cytomegalovirus.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.